Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants
NCT07508124Phase 4Recruiting
- Sponsor
- Baylor College of Medicine
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of betamethasone valerate 0.1% cream in urinary tract infection (UTI), sponsored by Baylor College of Medicine. Started May 2026; status: recruiting.
02
Drugs
betamethasone valerate 0.1% cream
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07508124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07508124.